Skip to content
sellWeak10b5-1 plan

David F Novack sold $190k of DVAX

President & COO at DYNAVAX TECHNOLOGIES CORP. 14,020 shares at an average of $13.58, traded Mar 18, 2025, filed Mar 20, 2025.

Warning score
32
Value
$190k
14,020 shares
Holdings after
8,078
-63% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    President
    +20
  • Trade size
    $190k at market
    +12
  • Share of holdings sold
    Sold 63% of holdings
    +20
  • Cluster
    No other insider selling within 14 days
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001029142-25-000063, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 18, 2025SOpen-market sale
Common Stock10b5-1
-14,020$13.58$190k8,078Mar 20, 2025

Related signals

Other insiders at DYNAVAX TECHNOLOGIES CORP and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
24Weak
DVAXbuy
DYNAVAX TECHNOLOGIES CORP
Scott Dunseth Myers
director
$41k
3,800 shares
+12%
42Moderate
DVAXsell
DYNAVAX TECHNOLOGIES CORP
Deep Track Biotechnology Master Fund, Ltd.
owner
$22M
2,065,137 shares
-12%
16Weak
DVAXsell10b5-1
DYNAVAX TECHNOLOGIES CORP
David F Novack
President & COO
$140k
10,000 shares
-55%
37Weak
DVAXsell10b5-1
DYNAVAX TECHNOLOGIES CORP
David F Novack
President & COO
$471k
32,764 shares
-60%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David F Novack sold $190k of DVAX | InsiderTell